SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Aegis Therapeutics, LLC Awarded Patent for Interferon Alpha, Beta, and Gamma Formulations That Eliminate Aggregation and Associated Immunogenicity and Are Suitable for Non-Invasive or Injectable Delivery
Your Message